Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Trump Tests Negative for Covid-19 on Consecutive Days, White House Physician Says -- 3rd update

10/12/2020 | 08:53pm EST

By Alex Leary and Daniela Hernandez

WASHINGTON -- President Trump tested negative for Covid-19 on consecutive days, White House physician Sean Conley said in a memo released Monday as Mr. Trump traveled to Florida for his first campaign rally since being treated for the virus.

Dr. Conley said tests and other measurements "have informed our medical team's assessment that the president is not infectious to others." The memo didn't specify when Mr. Trump was tested.

Mr. Trump was tested using Abbott Laboratories' BinaxNOW Covid-19 Ag Card, the memo said. The U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response Covid-19 antigen test that is roughly the size of a credit card.

Infectious-disease experts have cautioned against relying too much on results from rapid tests, especially early during an infection, because of sometimes unreliable results.

"It is important to note that this test was not used in isolation for the determination of the president's current negative status," the doctor's memo said, adding that other data were used.

Dr. Conley said Mr. Trump's medical team relied on data including viral load, viral culture data and so-called polymerase chain reaction (PCR) cycle measurements to clear Mr. Trump for travel.

PCR tests work by amplifying parts of the virus's genetic material. The higher the viral load -- meaning the more virus there is in a sample -- the fewer cycles of amplification that need to be done to hit a certain threshold. Scientists use that cycle count as a proxy for viral load and infectivity, but it isn't a direct test, said Abraar Karan, a global health physician at Brigham and Women's Hospital and Harvard Medical School.

Dr. Karan and others said the gold standard to measure infectiousness is viral culture, which Dr. Conley cited without detail. It is a test that aims to see whether the virus in a patient sample can infect other cells. To do those tests requires specialized facilities that have heightened biosafety protections and are only available at certain research or government institutions.

"This comprehensive data, in concert with the CDC's guidelines for removal of transmission-based precautions," informed the team's assessment, the White House memo said.

The White House has faced pressure to disclose more information about Mr. Trump's testing, and it has declined to say when the president last tested negative before disclosing his positive result around 1 a.m. on Oct. 2, only days after his first debate with Democratic presidential nominee Joe Biden. Mr. Trump didn't disclose a previous positive test, while awaiting the findings from a more thorough coronavirus screening, The Wall Street Journal reported.

Concerns over Mr. Trump's condition led to a decision to cancel a second debate with Mr. Biden, the former vice president, on Thursday in Miami after the president declined to participate virtually.

Mr. Trump left the White House on Monday afternoon and boarded Air Force One without wearing a mask. He spoke for about an hour to an outdoor crowd at the airport in Sanford, Fla., near Orlando, saying he felt "so powerful" and joking about entering the crowd to kiss people.

Some members of the tightly packed audience wore masks, but many people didn't. Mr. Trump didn't wear a mask.

It marked Mr. Trump's second public remarks since undergoing treatment for the virus. On Saturday, Mr. Trump spoke to hundreds of pro-police activists gathered on the White House lawn.

Dr. Conley on Saturday had also said that diagnostic tests showed there was "no longer evidence of actively replicating virus."

People infected with Covid-19 can stop isolating after 10 days have passed since the onset of symptoms, as long as they haven't had a fever in 24 hours and their other symptoms are improving, according to Centers for Disease Control and Prevention guidelines. For severe cases, the CDC says a person can be contagious for up to 20 days.

Mr. Trump was given a steroid, dexamethasone, typically recommended for severe cases of Covid-19. He also received the antiviral medication remdesivir, made by Gilead Sciences Inc.

He has lauded the use of an experimental Covid-19 drug from Regeneron Pharmaceuticals Inc.

Mr. Trump also said in a tweet Sunday that he was now immune. Twitter Inc. attached a warning to the president's tweet, saying it violated the platform's rules on spreading misleading or harmful information about Covid-19.

Write to Alex Leary at alex.leary@wsj.com and Daniela Hernandez at daniela.hernandez@wsj.com

(END) Dow Jones Newswires

10-12-20 2052ET

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.57% 107.53 Delayed Quote.23.80%
GILEAD SCIENCES, INC. -0.44% 60.86 Delayed Quote.-6.34%
REGENERON PHARMACEUTICALS -1.25% 498.84 Delayed Quote.32.85%
SANFORD LIMITED 0.00% 5 End-of-day quote.-37.11%
12/02ABBOTT LABORATORIES : FreeStyle Libre 2 Now Approved for Adults and Children wit..
11/20ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)
11/19ABBOTT LABORATORIES : Becomes first anchor sponsor of american diabetes associat..
11/18ABBOTT LABORATORIES : Launches the first infant formula in canada with an ingred..
11/17ABBOTT LABORATORIES : Launches the First Infant Formula in Canada with an Ingred..
11/17ABBOTT LABORATORIES : Named industry sustainability leader for the eighth year i..
11/16HHS Official Says The Agency Has Responded To Every State That Has Requested ..
11/16ABBOTT : Named Industry Sustainability Leader for the Eighth Year in a Row on th..
11/12ABBOTT LABORATORIES : Entry into a Material Definitive Agreement, Termination of..
11/12ABBVIE : Vice Chairman, Chief Commercial Officer Carlos Alban to Retire
More news
Financials (USD)
Sales 2020 33 873 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 43,9x
Yield 2020 1,34%
Capitalization 191 B 191 B -
EV / Sales 2020 5,97x
EV / Sales 2021 5,20x
Nbr of Employees 107 000
Free-Float 88,9%
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 118,44 $
Last Close Price 107,53 $
Spread / Highest target 20,9%
Spread / Average Target 10,2%
Spread / Lowest Target -23,7%
EPS Revisions
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC-0.86%152 346